REQUEST A DEMO
Total
USD $0.00
Search more companies

Immafarma OOO (Иммафарма ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Immafarma OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Immafarma OOO (Иммафарма ООО) is an enterprise located in Russia, with the main office in Moscow. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on November 19, 2002. There are currently 27 (2023) people employed by Immafarma OOO (Иммафарма ООО). In its most recent financial highlights, the company reported a net sales revenue drop of 73.26% in 2024. Its’ total assets recorded a growth of 29.82%. The enterprise’s net profit margin decreased by 183.24% in 2024.

Headquarters
Gamalei, 18, 11
Moscow; Moscow; Postal Code: 123098

Contact Details: Purchase the Immafarma OOO (Иммафарма ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Immafarma OOO (Иммафарма ООО) report to view the information.
Registered Capital:
Purchase the Immafarma OOO (Иммафарма ООО) report to view the information.
Financial Auditors:
Purchase the Immafarma OOO (Иммафарма ООО) report to view the information.
Incorporation Date:
November 19, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Tekhnofarma
99%
Company Performance
Financial values in the chart are available after Immafarma OOO (Иммафарма ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-73.26%
Total operating revenue
-73.26%
Operating profit (EBIT)
-128.29%
Net Profit (Loss) for the Period
-374.41%
Total Assets
29.82%
Total Equity
-45.55%
Operating Profit Margin (ROS)
-145.67%
Net Profit Margin
-183.24%
Return on Equity (ROE)
21.7%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?